4.5 Article

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-β1 in a cultured stellate cell line

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

BA Neuschwander-Tetri et al.

HEPATOLOGY (2003)

Article Biochemistry & Molecular Biology

Bezafibrate is a dual ligand for PPARα and PPARβ:: studies using null mice

JM Peters et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)